HEADER TRANSFERASE 10-MAY-17 5NXD TITLE LIM DOMAIN KINASE 2 (LIMK2) IN COMPLEX WITH TH-300 COMPND MOL_ID: 1; COMPND 2 MOLECULE: LIM DOMAIN KINASE 2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 330-632; COMPND 5 SYNONYM: LIMK-2; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: LIMK2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE ACTIN CYTOSKELETON INHIBITOR DFG-OUT, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.MATHEA,E.SALAH,T.HANKE,J.A.NEWMAN,S.OERUM,D.WANG,N.BURGESS-BROWN, AUTHOR 2 F.VON DELFT,C.H.ARROWSMITH,A.M.EDWARDS,C.BOUNTRA,A.N.BULLOCK,S.KNAPP REVDAT 1 24-MAY-17 5NXD 0 JRNL AUTH S.MATHEA,E.SALAH,T.HANKE,J.A.NEWMAN,S.OERUM,D.WANG, JRNL AUTH 2 N.BURGESS-BROWN,F.VON DELFT,C.H.ARROWSMITH,A.M.EDWARDS, JRNL AUTH 3 C.BOUNTRA,A.N.BULLOCK,S.KNAPP JRNL TITL LIM DOMAIN KINASE 2 (LIMK2)IN COMPLEX WITH TH-300 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0158 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 66.61 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 49231 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2594 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3709 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.80 REMARK 3 BIN R VALUE (WORKING SET) : 0.2760 REMARK 3 BIN FREE R VALUE SET COUNT : 188 REMARK 3 BIN FREE R VALUE : 0.2970 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4214 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 68 REMARK 3 SOLVENT ATOMS : 133 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.86 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.42000 REMARK 3 B22 (A**2) : 0.53000 REMARK 3 B33 (A**2) : -0.11000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.03000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.143 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.135 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.102 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.568 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.937 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4396 ; 0.018 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4127 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5959 ; 1.900 ; 1.967 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9545 ; 1.078 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 540 ; 5.953 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 171 ;38.117 ;23.977 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 731 ;13.476 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;18.688 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 673 ; 0.113 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5034 ; 0.011 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 906 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2172 ; 2.629 ; 2.802 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2173 ; 2.628 ; 2.802 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2703 ; 3.730 ; 4.187 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2704 ; 3.729 ; 4.187 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2224 ; 3.153 ; 3.068 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2225 ; 3.152 ; 3.067 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3256 ; 4.697 ; 4.490 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4913 ; 5.937 ;33.523 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4914 ; 5.936 ;33.523 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5NXD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-MAY-17. REMARK 100 THE DEPOSITION ID IS D_1200004883. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-APR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : XIA2 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51845 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 66.610 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.07200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.94 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.65900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4TPT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BIS-TRIS-PROPANE PH 7.5 0.2 M REMARK 280 NA2SO4 10% ETHYLENE GLYCOL 17% PEG3.35K, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.30250 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 328 REMARK 465 MET A 329 REMARK 465 GLU A 478 REMARK 465 GLU A 479 REMARK 465 ARG A 480 REMARK 465 LYS A 481 REMARK 465 ARG A 482 REMARK 465 ALA A 483 REMARK 465 PRO A 484 REMARK 465 MET A 485 REMARK 465 GLU A 486 REMARK 465 LYS A 487 REMARK 465 ALA A 488 REMARK 465 THR A 489 REMARK 465 THR A 490 REMARK 465 LYS A 491 REMARK 465 LYS A 492 REMARK 465 ARG A 493 REMARK 465 THR A 494 REMARK 465 LEU A 495 REMARK 465 ARG A 496 REMARK 465 LYS A 497 REMARK 465 ASN A 498 REMARK 465 ASP A 499 REMARK 465 ARG A 500 REMARK 465 LYS A 501 REMARK 465 LYS A 502 REMARK 465 ARG A 503 REMARK 465 TYR A 504 REMARK 465 THR A 505 REMARK 465 VAL A 506 REMARK 465 VAL A 507 REMARK 465 GLY A 508 REMARK 465 ASN A 509 REMARK 465 SER B 328 REMARK 465 MET B 329 REMARK 465 GLU B 478 REMARK 465 GLU B 479 REMARK 465 ARG B 480 REMARK 465 LYS B 481 REMARK 465 ARG B 482 REMARK 465 ALA B 483 REMARK 465 PRO B 484 REMARK 465 MET B 485 REMARK 465 GLU B 486 REMARK 465 LYS B 487 REMARK 465 ALA B 488 REMARK 465 THR B 489 REMARK 465 THR B 490 REMARK 465 LYS B 491 REMARK 465 LYS B 492 REMARK 465 ARG B 493 REMARK 465 THR B 494 REMARK 465 LEU B 495 REMARK 465 ARG B 496 REMARK 465 LYS B 497 REMARK 465 ASN B 498 REMARK 465 ASP B 499 REMARK 465 ARG B 500 REMARK 465 LYS B 501 REMARK 465 LYS B 502 REMARK 465 ARG B 503 REMARK 465 TYR B 504 REMARK 465 THR B 505 REMARK 465 VAL B 506 REMARK 465 VAL B 507 REMARK 465 GLY B 508 REMARK 465 ASN B 509 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 330 CG OD1 OD2 REMARK 470 GLU A 335 CD OE1 OE2 REMARK 470 LYS A 339 NZ REMARK 470 LYS A 351 CD CE NZ REMARK 470 ARG A 364 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 367 CG CD OE1 OE2 REMARK 470 GLU A 368 CG CD OE1 OE2 REMARK 470 LYS A 371 CG CD CE NZ REMARK 470 LYS A 378 NZ REMARK 470 LYS A 399 CE NZ REMARK 470 LYS A 521 CE NZ REMARK 470 LYS A 561 CE NZ REMARK 470 LYS A 566 CE NZ REMARK 470 ASP A 571 CG OD1 OD2 REMARK 470 GLU A 589 CD OE1 OE2 REMARK 470 GLU A 621 CD OE1 OE2 REMARK 470 LYS B 339 CE NZ REMARK 470 ARG B 364 CG CD NE CZ NH1 NH2 REMARK 470 CYS B 365 SG REMARK 470 GLU B 367 CD OE1 OE2 REMARK 470 GLU B 368 CG CD OE1 OE2 REMARK 470 LYS B 371 CG CD CE NZ REMARK 470 LYS B 378 NZ REMARK 470 LYS B 390 CE NZ REMARK 470 LYS B 397 CE NZ REMARK 470 ASP B 398 CG OD1 OD2 REMARK 470 LYS B 399 CG CD CE NZ REMARK 470 LYS B 400 CE NZ REMARK 470 LYS B 521 CE NZ REMARK 470 GLU B 589 CG CD OE1 OE2 REMARK 470 LYS B 596 CE NZ REMARK 470 GLU B 610 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ASP A 546 CB ASP A 546 CG 0.129 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY A 410 N - CA - C ANGL. DEV. = 15.7 DEGREES REMARK 500 ASP A 546 CB - CG - OD1 ANGL. DEV. = 5.7 DEGREES REMARK 500 ARG B 381 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 423 72.40 51.80 REMARK 500 CYS A 446 31.59 71.62 REMARK 500 ARG A 450 -4.58 76.14 REMARK 500 ASP A 451 39.33 -149.17 REMARK 500 ASP A 524 -158.26 -138.44 REMARK 500 GLN A 542 57.48 32.84 REMARK 500 ALA A 575 -13.18 74.07 REMARK 500 ALA B 352 -61.17 -96.21 REMARK 500 ARG B 364 152.36 -45.33 REMARK 500 CYS B 365 -50.58 -139.93 REMARK 500 LYS B 399 -4.61 68.21 REMARK 500 ARG B 450 -13.62 77.30 REMARK 500 ASP B 451 48.54 -141.95 REMARK 500 ASP B 524 -158.86 -135.85 REMARK 500 ALA B 575 -18.50 72.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9D8 A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9D8 B 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 702 DBREF 5NXD A 330 632 UNP P53671 LIMK2_HUMAN 330 632 DBREF 5NXD B 330 632 UNP P53671 LIMK2_HUMAN 330 632 SEQADV 5NXD SER A 328 UNP P53671 EXPRESSION TAG SEQADV 5NXD MET A 329 UNP P53671 EXPRESSION TAG SEQADV 5NXD SER B 328 UNP P53671 EXPRESSION TAG SEQADV 5NXD MET B 329 UNP P53671 EXPRESSION TAG SEQRES 1 A 305 SER MET ASP LEU ILE HIS GLY GLU VAL LEU GLY LYS GLY SEQRES 2 A 305 PHE PHE GLY GLN ALA ILE LYS VAL THR HIS LYS ALA THR SEQRES 3 A 305 GLY LYS VAL MET VAL MET LYS GLU LEU ILE ARG CYS ASP SEQRES 4 A 305 GLU GLU THR GLN LYS THR PHE LEU THR GLU VAL LYS VAL SEQRES 5 A 305 MET ARG SER LEU ASP HIS PRO ASN VAL LEU LYS PHE ILE SEQRES 6 A 305 GLY VAL LEU TYR LYS ASP LYS LYS LEU ASN LEU LEU THR SEQRES 7 A 305 GLU TYR ILE GLU GLY GLY THR LEU LYS ASP PHE LEU ARG SEQRES 8 A 305 SER MET ASP PRO PHE PRO TRP GLN GLN LYS VAL ARG PHE SEQRES 9 A 305 ALA LYS GLY ILE ALA SER GLY MET ALA TYR LEU HIS SER SEQRES 10 A 305 MET CYS ILE ILE HIS ARG ASP LEU ASN SER HIS ASN CYS SEQRES 11 A 305 LEU ILE LYS LEU ASP LYS THR VAL VAL VAL ALA ASP PHE SEQRES 12 A 305 GLY LEU SER ARG LEU ILE VAL GLU GLU ARG LYS ARG ALA SEQRES 13 A 305 PRO MET GLU LYS ALA THR THR LYS LYS ARG THR LEU ARG SEQRES 14 A 305 LYS ASN ASP ARG LYS LYS ARG TYR THR VAL VAL GLY ASN SEQRES 15 A 305 PRO TYR TRP MET ALA PRO GLU MET LEU ASN GLY LYS SER SEQRES 16 A 305 TYR ASP GLU THR VAL ASP ILE PHE SER PHE GLY ILE VAL SEQRES 17 A 305 LEU CYS GLU ILE ILE GLY GLN VAL TYR ALA ASP PRO ASP SEQRES 18 A 305 CYS LEU PRO ARG THR LEU ASP PHE GLY LEU ASN VAL LYS SEQRES 19 A 305 LEU PHE TRP GLU LYS PHE VAL PRO THR ASP CYS PRO PRO SEQRES 20 A 305 ALA PHE PHE PRO LEU ALA ALA ILE CYS CYS ARG LEU GLU SEQRES 21 A 305 PRO GLU SER ARG PRO ALA PHE SER LYS LEU GLU ASP SER SEQRES 22 A 305 PHE GLU ALA LEU SER LEU TYR LEU GLY GLU LEU GLY ILE SEQRES 23 A 305 PRO LEU PRO ALA GLU LEU GLU GLU LEU ASP HIS THR VAL SEQRES 24 A 305 SER MET GLN TYR GLY LEU SEQRES 1 B 305 SER MET ASP LEU ILE HIS GLY GLU VAL LEU GLY LYS GLY SEQRES 2 B 305 PHE PHE GLY GLN ALA ILE LYS VAL THR HIS LYS ALA THR SEQRES 3 B 305 GLY LYS VAL MET VAL MET LYS GLU LEU ILE ARG CYS ASP SEQRES 4 B 305 GLU GLU THR GLN LYS THR PHE LEU THR GLU VAL LYS VAL SEQRES 5 B 305 MET ARG SER LEU ASP HIS PRO ASN VAL LEU LYS PHE ILE SEQRES 6 B 305 GLY VAL LEU TYR LYS ASP LYS LYS LEU ASN LEU LEU THR SEQRES 7 B 305 GLU TYR ILE GLU GLY GLY THR LEU LYS ASP PHE LEU ARG SEQRES 8 B 305 SER MET ASP PRO PHE PRO TRP GLN GLN LYS VAL ARG PHE SEQRES 9 B 305 ALA LYS GLY ILE ALA SER GLY MET ALA TYR LEU HIS SER SEQRES 10 B 305 MET CYS ILE ILE HIS ARG ASP LEU ASN SER HIS ASN CYS SEQRES 11 B 305 LEU ILE LYS LEU ASP LYS THR VAL VAL VAL ALA ASP PHE SEQRES 12 B 305 GLY LEU SER ARG LEU ILE VAL GLU GLU ARG LYS ARG ALA SEQRES 13 B 305 PRO MET GLU LYS ALA THR THR LYS LYS ARG THR LEU ARG SEQRES 14 B 305 LYS ASN ASP ARG LYS LYS ARG TYR THR VAL VAL GLY ASN SEQRES 15 B 305 PRO TYR TRP MET ALA PRO GLU MET LEU ASN GLY LYS SER SEQRES 16 B 305 TYR ASP GLU THR VAL ASP ILE PHE SER PHE GLY ILE VAL SEQRES 17 B 305 LEU CYS GLU ILE ILE GLY GLN VAL TYR ALA ASP PRO ASP SEQRES 18 B 305 CYS LEU PRO ARG THR LEU ASP PHE GLY LEU ASN VAL LYS SEQRES 19 B 305 LEU PHE TRP GLU LYS PHE VAL PRO THR ASP CYS PRO PRO SEQRES 20 B 305 ALA PHE PHE PRO LEU ALA ALA ILE CYS CYS ARG LEU GLU SEQRES 21 B 305 PRO GLU SER ARG PRO ALA PHE SER LYS LEU GLU ASP SER SEQRES 22 B 305 PHE GLU ALA LEU SER LEU TYR LEU GLY GLU LEU GLY ILE SEQRES 23 B 305 PRO LEU PRO ALA GLU LEU GLU GLU LEU ASP HIS THR VAL SEQRES 24 B 305 SER MET GLN TYR GLY LEU HET 9D8 A 701 30 HET EDO A 702 4 HET 9D8 B 701 30 HET EDO B 702 4 HETNAM 9D8 4-[(3-CHLOROPHENYL)SULFAMOYL]-~{N}-(PHENYLMETHYL)-~{N}- HETNAM 2 9D8 PROPYL-BENZAMIDE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 9D8 2(C23 H23 CL N2 O3 S) FORMUL 4 EDO 2(C2 H6 O2) FORMUL 7 HOH *133(H2 O) HELIX 1 AA1 GLY A 340 GLN A 344 5 5 HELIX 2 AA2 ASP A 366 LEU A 383 1 18 HELIX 3 AA3 THR A 412 SER A 419 1 8 HELIX 4 AA4 PRO A 424 MET A 445 1 22 HELIX 5 AA5 ALA A 514 ASN A 519 1 6 HELIX 6 AA6 THR A 526 GLY A 541 1 16 HELIX 7 AA7 ASP A 546 LEU A 550 5 5 HELIX 8 AA8 ASN A 559 VAL A 568 1 10 HELIX 9 AA9 ALA A 575 CYS A 584 1 10 HELIX 10 AB1 GLU A 587 ARG A 591 5 5 HELIX 11 AB2 ALA A 593 GLY A 609 1 17 HELIX 12 AB3 PRO A 616 TYR A 630 1 15 HELIX 13 AB4 GLY B 340 GLN B 344 5 5 HELIX 14 AB5 ASP B 366 GLU B 376 1 11 HELIX 15 AB6 GLU B 376 SER B 382 1 7 HELIX 16 AB7 THR B 412 SER B 419 1 8 HELIX 17 AB8 PRO B 424 MET B 445 1 22 HELIX 18 AB9 ALA B 514 ASN B 519 1 6 HELIX 19 AC1 THR B 526 GLY B 541 1 16 HELIX 20 AC2 ASP B 546 LEU B 550 5 5 HELIX 21 AC3 ASN B 559 VAL B 568 1 10 HELIX 22 AC4 ALA B 575 CYS B 584 1 10 HELIX 23 AC5 GLU B 587 ARG B 591 5 5 HELIX 24 AC6 ALA B 593 GLY B 609 1 17 HELIX 25 AC7 PRO B 616 GLY B 631 1 16 SHEET 1 AA1 5 LEU A 331 VAL A 336 0 SHEET 2 AA1 5 ILE A 346 HIS A 350 -1 O LYS A 347 N GLU A 335 SHEET 3 AA1 5 VAL A 356 LEU A 362 -1 O MET A 357 N VAL A 348 SHEET 4 AA1 5 LYS A 400 GLU A 406 -1 O THR A 405 N VAL A 358 SHEET 5 AA1 5 PHE A 391 LYS A 397 -1 N GLY A 393 O LEU A 404 SHEET 1 AA2 2 ILE A 447 ILE A 448 0 SHEET 2 AA2 2 LEU A 475 ILE A 476 -1 O LEU A 475 N ILE A 448 SHEET 1 AA3 2 CYS A 457 ILE A 459 0 SHEET 2 AA3 2 VAL A 465 VAL A 467 -1 O VAL A 466 N LEU A 458 SHEET 1 AA4 5 LEU B 331 VAL B 336 0 SHEET 2 AA4 5 ILE B 346 HIS B 350 -1 O LYS B 347 N GLY B 334 SHEET 3 AA4 5 VAL B 356 GLU B 361 -1 O MET B 359 N ILE B 346 SHEET 4 AA4 5 LYS B 400 GLU B 406 -1 O LEU B 403 N LYS B 360 SHEET 5 AA4 5 PHE B 391 LYS B 397 -1 N LEU B 395 O ASN B 402 SHEET 1 AA5 2 ILE B 447 ILE B 448 0 SHEET 2 AA5 2 LEU B 475 ILE B 476 -1 O LEU B 475 N ILE B 448 SHEET 1 AA6 2 CYS B 457 ILE B 459 0 SHEET 2 AA6 2 VAL B 465 VAL B 467 -1 O VAL B 466 N LEU B 458 SITE 1 AC1 17 LYS A 360 GLU A 361 MET A 380 LEU A 383 SITE 2 AC1 17 VAL A 388 LEU A 389 PHE A 391 LEU A 403 SITE 3 AC1 17 THR A 405 LEU A 442 HIS A 449 VAL A 467 SITE 4 AC1 17 ALA A 468 ASP A 469 PHE A 470 LEU A 472 SITE 5 AC1 17 ARG A 474 SITE 1 AC2 6 VAL A 358 LEU A 389 THR A 405 GLU A 406 SITE 2 AC2 6 ILE A 408 LEU A 458 SITE 1 AC3 16 LYS B 360 GLU B 361 MET B 380 LEU B 383 SITE 2 AC3 16 VAL B 388 LEU B 389 PHE B 391 LEU B 403 SITE 3 AC3 16 THR B 405 HIS B 449 VAL B 467 ALA B 468 SITE 4 AC3 16 ASP B 469 PHE B 470 LEU B 472 ARG B 474 SITE 1 AC4 6 VAL B 358 LEU B 389 THR B 405 GLU B 406 SITE 2 AC4 6 TYR B 407 ILE B 408 CRYST1 63.275 66.605 82.124 90.00 97.43 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015804 0.000000 0.002062 0.00000 SCALE2 0.000000 0.015014 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012280 0.00000 MASTER 435 0 4 25 18 0 13 6 0 0 0 48 END